Results 111 to 120 of about 117,431 (260)

Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany—A prospective, multicentre trial

British Journal of Haematology, EarlyView.
Summary Young adults (YA) are particularly affected by comorbid conditions following allogeneic haematopoietic stem cell transplantation (alloHSCT), as they have to live with them for many years. This is the first multicentre prospective study investigating sequelae after alloHSCT in YA in Germany. In total, 107 patients who survived relapse‐free until
Pauline Rocke, Lena Tandetzky, Daniel Wolff, Katharina Egger‐Heidrich, Daniela Heidenreich, Kerstin Schaefer‐Eckart, Eva Wagner‐Drouet, Jochen J. Frietsch, Andreas Hochhaus, Inken Hilgendorf   +9 more
wiley   +1 more source

Pathologically confirmed pancreatic hamartoma after surgical resection with an aldosterone-producing adrenal tumor: a case report. [PDF]

J Surg Case Rep, 2023
Kim JH, Yoon SH, Choi JA, Kwak JH, Kim M, Kim SH.   +5 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Adrenal tumor microenvironment: hormone-immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities. [PDF]

Front Immunol
Chen S, Gao X.
europepmc   +1 more source

Nursing effect of continuous nursing intervention based on "Internet Plus" on patients with severe adrenal tumor. [PDF]

Medicine (Baltimore), 2023
Yao J, He W, Chen H, Qi Y.
europepmc   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Perspectives on Adrenal Tumor Surgery. [PDF]

Medicina (Kaunas)
Baston C, Parosanu A, Moldoveanu O, Discalicău L, Visinescu P, Precup A, Sinescu I.   +6 more
europepmc   +1 more source

The ADRENAL score: A comprehensive scoring system for standardized evaluation of adrenal tumor. [PDF]

Front Endocrinol (Lausanne), 2022
Zhou X, Li X, Fu B, Liu W, Zhang C, Xia Y, Gong H, Zhu L, Lei E, Kaplan J, Deng Y, Eun D, Wang G.   +12 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Editorial: Enhancing adrenal tumor diagnostics: biomarkers and molecular mechanisms. [PDF]

Front Endocrinol (Lausanne)
Glinicki P, Falhammar H.
europepmc   +1 more source